Saltar al contenido principal

Para Química, Fabricación y Controles

Para Química, Fabricación y Controles

Posters  -  14 May 2024

LC-MS for improving decision making and mitigating risk in process development

Reciente

Artículos

Articles  —  27 September Sep 2025

eBOOK: mRNA-LNPs for vaccine and gene therapy indications

Read More about eBOOK: mRNA-LNPs for vaccine and gene therapy indications
Articles  —  24 July Jul 2025

Gene therapy in-use and device compatibility studies

Read More about Gene therapy in-use and device compatibility studies
Articles  —  2 July Jul 2025

Analytical procedure development following ICH Q14: An AQbD approach

Read More about Analytical procedure development following ICH Q14: An AQbD approach

Hojas informativas

Posters  —  27 September Sep 2023

Evaluating the effect of formulation on the uptake of a Zika virus subunit vaccine candidate by antigen-presenting cells

Read More about Evaluating the effect of formulation on the uptake of a Zika virus subunit vaccine candidate by antigen-presenting cells
Posters  —  27 September Sep 2023

LNP vaccine formulation screening for cellular uptake using BODIPY-labeled lipid nanoparticles

Read More about LNP vaccine formulation screening for cellular uptake using BODIPY-labeled lipid nanoparticles
Posters  —  9 May May 2023

Multi-attribute monitoring with waters_connect™ peptide MAM: A formulation development case study

Read More about Multi-attribute monitoring with waters_connect™ peptide MAM: A formulation development case study

Carteles

Posters  —  27 April Apr 2026

Semi-automated liquid handling: Mitigating analyst-to-analyst variability in QC bioassays

Read More about Semi-automated liquid handling: Mitigating analyst-to-analyst variability in QC bioassays
Posters  —  23 March Mar 2026

Semi-automated liquid handling: Mitigating analyst-to-analyst variability in QC bioassays

Read More about Semi-automated liquid handling: Mitigating analyst-to-analyst variability in QC bioassays
Posters  —  27 January Jan 2026

Higher order structure (HOS) analysis of Yersinia pestis virulence factor Caf1 polymerization using carboxyl-group foot-printing

Read More about Higher order structure (HOS) analysis of Yersinia pestis virulence factor Caf1 polymerization using carboxyl-group foot-printing

Videos y seminarios web

PROFUNDA EXPERIENCIA ANALÍTICA BIOFARMACÉUTICA Y OBJETIVIDAD CUANDO IMPORTA MÁS

Científicos de servicios biofarmacéuticos de CMC

Cuente con la profunda experiencia analítica biofarmacéutica de Labcorp Biopharmaceutical Chemistry, Manufacturing and Control (CMC) Services para ayudarlo a impulsar el avance de su proceso de desarrollo de medicamentos. Expertos en caracterización, desarrollo de formulaciones y desarrollo analítico, así como en pruebas de control de calidad, nuestros expertos en la materia se asociarán con usted para avanzar hábilmente en sus programas y ayudarlo a evitar errores comunes.

Allan Watkinson, PhD

 Dir, BioPharm Dev Bio, CMC

Anas Tomeh, PhD

 Research and Development Scientist

Caroline Heap, PhD

 Sr Lead Scientist | Supervisory Organization

Colin Guy, PhD

 Senior Manager Assay Development, Method Development & Validation

Hazel Staton

 Lead Scientist, GMP R&D

Henry Fisher, PhD

 Assay Development Scientist, Method Development & Validation

Leonard Bell, PhD

 Lead Assay Development Scientist, Method Development & Validation

Rachel Smith, PhD

 Assay Development Scientist, Method Development & Validation

Tobey Gooding

 Quality Control Scientist III, Quality Control

Warren Rowland

 Senior Quality Control Section Manager, Quality Control